Silom Medical is respected as a quality leader in the industry, with an experienced, in-house sales force and operates a 32,000 sq. meter manufacturing facility in Ayutthaya with a production capacity of 500 million tablets/capsules and 37 million sterile units per year.
Silom Medical has delivered consistent, year-on-year growth in revenue and profit over the past 15 years, doubling industry performance. The Company is in the top-five position in the Thai generic pharmaceutical market, with leading positions in the ophthalmic and respiratory therapeutic categories and a strong cardiovascular, women’s health and oncology franchise.
In April 2014, Silom Medical became a part of Actavis plc, which was subsequently acquired by Teva Pharmaceutical Industries in August 2016. Silom Medical's diverse product portfolio, when combined with Teva's generics portfolio and specialty medicine franchises in the areas of CNS, respiratory, oncology, and women’s health will provide consumers in Thailand with expanded access to a larger portfolio of affordable high quality medicines and the increased opportunity to benefit from products in development for the market.